CVS Health Corp (CVS)
67.58
+0.77 (1.15%)
NYSE · Last Trade: Jun 24th, 5:38 PM EDT
Several major U.S. health insurers announce they will voluntarily speed up and simplify the prior authorization process.
Via Benzinga · June 23, 2025
Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing.
Via Benzinga · June 21, 2025
Via Benzinga · June 20, 2025
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via Benzinga · June 20, 2025
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline.
Via Stocktwits · June 19, 2025
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers.
Via Stocktwits · June 16, 2025
Several major large-cap stocks, each with a market capitalization of over $30 billion, have recently announced notable increases to their quarterly dividends. These updates, aligned with recent shareholder meetings and strategic decisions, reflect efforts to enhance shareholder value and demonstrate financial strength.
Via MarketBeat · June 16, 2025
Via The Motley Fool · June 14, 2025

Humana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses.
Via Benzinga · June 5, 2025

Nearly 80% of S&P 500 firms beat Q1 earnings forecasts. Profit growth hit 13.3%, led by tech and health care, says FactSet.
Via Benzinga · June 3, 2025

Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets.
Via Benzinga · June 3, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · May 30, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.
However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Via StockStory · May 30, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?
Via Investor's Business Daily · May 29, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst performers in the health insurance providers industry.
Via StockStory · May 28, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · May 28, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · May 28, 2025
Via The Motley Fool · May 27, 2025
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Via StockStory · May 27, 2025
NRG Energy Inc leads S&P 500's 2024 leaderboard with 70% YTD gain. Palantir follows with 64% surge, only stock from Cathie Wood's ARK funds in top performers.
Via Benzinga · May 26, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via Benzinga · May 24, 2025